文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

lncSLERT通过RBM15介导的m6A修饰下调HUNK表达促进结直肠癌肝转移。

lncSLERT Promotes Liver Metastasis in Colorectal Cancer by Down-Regulating HUNK Expression via RBM15-Mediated m6A Modification.

作者信息

Wang Lin, Zhao Liming, Liu Jialiang, Cheng Pu, Han Mingyu, Zheng Zhaoxu

机构信息

The State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People's Republic of China.

Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

出版信息

Onco Targets Ther. 2025 May 9;18:631-646. doi: 10.2147/OTT.S514001. eCollection 2025.


DOI:10.2147/OTT.S514001
PMID:40371234
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12075449/
Abstract

BACKGROUND: Metastasis is a hallmark of cancer and the leading cause of cancer-related mortality. However, the mechanism underlying liver metastasis in colorectal cancer (CRC) remains incompletely understood. This study explores the role of long non-coding RNA (lncRNA) SLERT in promoting CRC liver metastasis by downregulating HUNK expression. METHODS: SLERT expression levels in CRC tissues were analyzed and correlated with patient survival outcomes. Functional assays, including migration and invasion assays, were performed to assess the impact of SLERT knockdown and overexpression on metastatic behavior. Mechanistic studies examined SLERT's interaction with the RNA-binding protein RBM15 and its effect on HUNK mRNA stability. The subcellular localization of SLERT was also determined. RESULTS: SLERT was significantly upregulated in CRC tissues and associated with poor survival outcomes. Silencing SLERT inhibited CRC cell migration and invasion, whereas its overexpression enhanced these metastatic properties. Mechanistically, SLERT interacted with RBM15, impairing its ability to stabilize HUNK mRNA, leading to decreased HUNK expression and increased metastatic potential. SLERT was primarily localized in the cytoplasm, indicating its active role in gene regulation within the tumor microenvironment. CONCLUSION: LERT promotes liver metastasis in CRC by downregulating HUNK expression through RBM15-mediated mRNA destabilization. These findings suggest that SLERT could serve as a diagnostic biomarker and therapeutic target. Targeting SLERT or restoring HUNK expression may provide novel strategies to combat CRC liver metastasis and improve patient prognosis.

摘要

背景:转移是癌症的一个标志,也是癌症相关死亡的主要原因。然而,结直肠癌(CRC)肝转移的潜在机制仍未完全明确。本研究探讨长链非编码RNA(lncRNA)SLERT通过下调HUNK表达促进CRC肝转移的作用。 方法:分析CRC组织中SLERT的表达水平,并将其与患者生存结果相关联。进行了包括迁移和侵袭试验在内的功能试验,以评估SLERT敲低和过表达对转移行为的影响。机制研究检测了SLERT与RNA结合蛋白RBM15的相互作用及其对HUNK mRNA稳定性的影响。还确定了SLERT的亚细胞定位。 结果:SLERT在CRC组织中显著上调,并与不良生存结果相关。沉默SLERT可抑制CRC细胞迁移和侵袭,而其过表达则增强了这些转移特性。机制上,SLERT与RBM15相互作用,损害其稳定HUNK mRNA的能力,导致HUNK表达降低和转移潜能增加。SLERT主要定位于细胞质,表明其在肿瘤微环境中的基因调控中发挥积极作用。 结论:SLERT通过RBM15介导的mRNA去稳定作用下调HUNK表达,从而促进CRC肝转移。这些发现表明,SLERT可作为一种诊断生物标志物和治疗靶点。靶向SLERT或恢复HUNK表达可能为对抗CRC肝转移和改善患者预后提供新策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e6/12075449/462bf838b2db/OTT-18-631-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e6/12075449/565338a1a5c8/OTT-18-631-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e6/12075449/d00303886fb3/OTT-18-631-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e6/12075449/19b39aa28677/OTT-18-631-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e6/12075449/2822a6e088aa/OTT-18-631-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e6/12075449/ac0986fe90c6/OTT-18-631-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e6/12075449/462bf838b2db/OTT-18-631-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e6/12075449/565338a1a5c8/OTT-18-631-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e6/12075449/d00303886fb3/OTT-18-631-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e6/12075449/19b39aa28677/OTT-18-631-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e6/12075449/2822a6e088aa/OTT-18-631-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e6/12075449/ac0986fe90c6/OTT-18-631-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e6/12075449/462bf838b2db/OTT-18-631-g0006.jpg

相似文献

[1]
lncSLERT Promotes Liver Metastasis in Colorectal Cancer by Down-Regulating HUNK Expression via RBM15-Mediated m6A Modification.

Onco Targets Ther. 2025-5-9

[2]
SLERT, as a novel biomarker, orchestrates endometrial cancer metastasis via regulation of BDNF/TRKB signaling.

World J Surg Oncol. 2023-1-31

[3]
Knockdown RBM15 Inhibits Colorectal Cancer Cell Proliferation and Metastasis Via N6-Methyladenosine (m6A) Modification of MyD88 mRNA.

Cancer Biother Radiopharm. 2022-12

[4]
Mechanism of RBM15 in the malignant proliferation of colorectal cancer cells through regulating the stability of LncRNA FGD5-AS1 via m6A modification.

Exp Cell Res. 2025-1-15

[5]
Regulatory mechanism of RNA binding motif protein 15-mediated N methyladenosine modification in proliferation, invasion, and migration of colorectal cancer cells.

Environ Toxicol. 2023-11

[6]
SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.

J Transl Med. 2022-5-4

[7]
RBM15-mediated m6A modification of XPR1 promotes the malignant progression of lung adenocarcinoma.

Naunyn Schmiedebergs Arch Pharmacol. 2025-2-10

[8]
RNA methylase RBM15 facilitates malignant progression of colorectal cancer through regulating E2F2 in an m6A modification-dependent manner.

J Biochem Mol Toxicol. 2024-11

[9]
Hypoxia inhibits HUNK kinase activity to induce epithelial-mesenchymal transition.

Biochem Biophys Res Commun. 2023-11-12

[10]
LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification.

J Exp Clin Cancer Res. 2021-2-1

本文引用的文献

[1]
Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial.

Lancet. 2024-9-21

[2]
A network meta-analysis of efficacy and safety for first-line and maintenance therapies in patients with unresectable colorectal liver metastases.

Front Pharmacol. 2024-7-26

[3]
METTL16 regulates the mRNA stability of FBXO5 via m6A modification to facilitate the malignant behavior of breast cancer.

Cancer Metab. 2024-7-25

[4]
Long non-coding RNAs in cancer: multifaceted roles and potential targets for immunotherapy.

Mol Cell Biochem. 2024-12

[5]
Changing perspectives in the treatment of colorectal liver metastases.

Br J Surg. 2024-1-3

[6]
lncRNA-microRNA axis in cancer drug resistance: particular focus on signaling pathways.

Med Oncol. 2024-1-9

[7]
A Novel TGF-β-Related Signature for Predicting Prognosis, Tumor Microenvironment, and Therapeutic Response in Colorectal Cancer.

Biochem Genet. 2024-8

[8]
EMT-induced immune evasion: connecting the dots from mechanisms to therapy.

Clin Exp Med. 2023-12

[9]
The modes of angiogenesis: an updated perspective.

Angiogenesis. 2023-11

[10]
Unveiling the functional paradigm of exosome-derived long non-coding RNAs (lncRNAs) in cancer: based on a narrative review and systematic review.

J Cancer Res Clin Oncol. 2023-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索